Skip to Main Content

Author Details

M Elizabeth Halloran
University of Washington, Fred Hutchinson Cancer Center
1989
240
57
PMIDPaper TitleJournal TitlePublished Year
35932359Evaluating the Mediating Role of Recall of Intervention Knowledge in the Relationship Between a Peer-Driven Intervention and HIV Risk Behaviors Among People Who Inject Drugs.AIDS Behav2023
37908408Propensity Score in the Face of Interference: Discussion of.Obs Stud2023
37424310Incidence of SARS-CoV-2 infection and associated risk factors among staff and residents at homeless shelters in King County, Washington: an active surveillance study.Epidemiol Infect2023
37277329Estimating the impact of COVID-19 vaccine inequities: a modeling study.Nat Commun2023
37399393Multimodeling approach to evaluating the efficacy of layering pharmaceutical and nonpharmaceutical interventions for influenza pandemics.Proc Natl Acad Sci U S A2023
37365505Rapid review and meta-analysis of serial intervals for SARS-CoV-2 Delta and Omicron variants.BMC Infect Dis2023
37295130Association between pertussis vaccination coverage and other sociodemographic factors and pertussis incidence using surveillance data.Epidemics2023
36788358Finding influential subjects in a network using a causal framework.Biometrics2023
36839598Methods for Assessing Spillover in Network-Based Studies of HIV/AIDS Prevention among People Who Use Drugs.Pathogens2023
36932663Covariate-constrained randomization with cluster selection and substitution.Clin Trials2023
32672510Validity of university students' self-reported vaccination status after a meningococcal B outbreak.J Am Coll Health2022
35696558Quantifying the importance and location of SARS-CoV-2 transmission events in large metropolitan areas.Proc Natl Acad Sci U S A2022
35721226Using social contact data to improve the overall effect estimate of a cluster-randomized influenza vaccination program in Senegal.J R Stat Soc Ser C Appl Stat2022
35482308Household Secondary Attack Rates of SARS-CoV-2 by Variant and Vaccination Status: An Updated Systematic Review and Meta-analysis.JAMA Netw Open2022
36415459Estimating the impact of COVID-19 vaccine allocation inequities: a modeling study.medRxiv2022
35866633A platform trial design for preventive vaccines against Marburg virus and other emerging infectious disease threats.Clin Trials2022
36305040Spillover benefit of pre-exposure prophylaxis for HIV prevention: evaluating the importance of effect modification using an agent-based model.Epidemiol Infect2022
36152668Evolutionary consequences of delaying intervention for monkeypox.Lancet2022
33768557Inverse probability weighted estimators of vaccine effects accommodating partial interference and censoring.Biometrics2022
35271331Protecting the herd with vaccination.Science2022
34420223Discussion on "Estimating vaccine efficacy over time after a randomized study is unblinded" by Anastasios A. Tsiatis and Marie Davidian.Biometrics2022
32974644Incorporating Real-time Influenza Detection Into the Test-negative Design for Estimating Influenza Vaccine Effectiveness: The Real-time Test-negative Design (rtTND).Clin Infect Dis2021
33881527Estimating Population-Level Effects of the Acellular Pertussis Vaccine Using Routinely Collected Immunization Data.Clin Infect Dis2021
33791745Cryptic transmission of SARS-CoV-2 and the first COVID-19 wave in Europe and the United States.medRxiv2021
34613812Dengue and Zika virus infections in children elicit cross-reactive protective and enhancing antibodies that persist long term.Sci Transl Med2021
34493409Durability of protection after 5 doses of acellular pertussis vaccine among 5-9 year old children in King County, Washington.Vaccine2021
34374773Association of Diphtheria-Tetanus-Acellular Pertussis Vaccine Timeliness and Number of Doses With Age-Specific Pertussis Risk in Infants and Young Children.JAMA Netw Open2021
34628108Challenges of evaluating and modelling vaccination in emerging infectious diseases.Epidemics2021
34626549Transition to endemicity: Understanding COVID-19.Immunity2021
34448865Factors Associated With Household Transmission of SARS-CoV-2: An Updated Systematic Review and Meta-analysis.JAMA Netw Open2021
34218667Using simulated infectious disease outbreaks to inform site selection and sample size for individually randomized vaccine trials during an ongoing epidemic.Clin Trials2021
33963578Comment on AIDS and COVID-19: A tale of two pandemics and the role of statisticians.Stat Med2021
34013330Modeling the Impacts of Clinical Influenza Testing on Influenza Vaccine Effectiveness Estimates.J Infect Dis2021
33280855Cost-effectiveness of live-attenuated influenza vaccination among school-age children.Vaccine2021
33165566Estimates of Inactivated Influenza Vaccine Effectiveness Among Children in Senegal: Results From 2 Consecutive Cluster-Randomized Controlled Trials in 2010 and 2011.Clin Infect Dis2021
33476567Household transmission of SARS-CoV-2 and risk factors for susceptibility and infectivity in Wuhan: a retrospective observational study.Lancet Infect Dis2021
33128066Disseminated Effects in Agent-Based Models: A Potential Outcomes Framework and Application to Inform Preexposure Prophylaxis Coverage Levels for HIV Prevention.Am J Epidemiol2021
33264543Placebo-Controlled Trials of Covid-19 Vaccines - Why We Still Need Them.N Engl J Med2021
31056675Successes and Failures of the Live-attenuated Influenza Vaccine: Can We Do Better?Clin Infect Dis2020
31971229Designing a Study of Correlates of Risk for Ebola Vaccination.Am J Epidemiol2020
33315116Household Transmission of SARS-CoV-2: A Systematic Review and Meta-analysis.JAMA Netw Open2020
33032661The TIRS trial: protocol for a cluster randomized controlled trial assessing the efficacy of preventive targeted indoor residual spraying to reduce Aedes-borne viral illnesses in Merida, Mexico.Trials2020
32855339Zika virus infection enhances future risk of severe dengue disease.Science2020
32710864Achieving coordinated national immunity and cholera elimination in Haiti through vaccination: a modelling study.Lancet Glob Health2020
32766596Household transmission of SARS-CoV-2: a systematic review and meta-analysis of secondary attack rate.medRxiv2020
32676609Estimating the establishment of local transmission and the cryptic phase of the COVID-19 pandemic in the USA.medRxiv2020
32759985Modelling the impact of testing, contact tracing and household quarantine on second waves of COVID-19.Nat Hum Behav2020
33012602Ensemble forecast modeling for the design of COVID-19 vaccine efficacy trials.Vaccine2020
32247326Evolving epidemiology and transmission dynamics of coronavirus disease 2019 outside Hubei province, China: a descriptive and modelling study.Lancet Infect Dis2020
32415834Temporal Confounding in the Test-Negative Design.Am J Epidemiol2020
  • 1 - 50 of 240

Recommended Authors

Matt D T Hitchings
College of Public Health and Health Professions, University of Florida
Career Start Year 2017
Number of shared co-authors 2
Temitope Folaranmi
Merck & Co., Inc.
Career Start Year 2014
Number of shared co-authors 0
Edouard Lhomme
University of Bordeaux, Inserm, EUCLID/F-CRIN Clinical Trials Platform
Career Start Year 2013
Number of shared co-authors 1
Huong Q McLean
Marshfield Clinic Research Institute
Career Start Year 2012
Number of shared co-authors 10
Maria E Sundaram
Dalla Lana School of Public Health, University of Toronto
Career Start Year 2012
Number of shared co-authors 5
Benjamin M Althouse
University of Washington
Career Start Year 2010
Number of shared co-authors 3
Catherine F Houlihan
University College London Hospitals National Health Service Foundation Trust
Career Start Year 2010
Number of shared co-authors 4
Daniel M Weinberger
Yale School of Public Health, Yale University
Career Start Year 2008
Number of shared co-authors 1
Christopher Fonnesbeck
Vanderbilt University
Career Start Year 2008
Number of shared co-authors 2
Jay V DePasse
USA Pittsburgh Supercomputing Center (PSC) at Carnegie Mellon University
Career Start Year 2007
Number of shared co-authors 2
David M Brett-Major
College of Public Health, University of Nebraska Medical Center
Career Start Year 2006
Number of shared co-authors 4
Jason R Andrews
Stanford University
Career Start Year 2006
Number of shared co-authors 3
Natalie M Bowman
University of North Carolina at Chapel Hill
Career Start Year 2006
Number of shared co-authors 7
Saad B Omer
Yale School of Public Health
Career Start Year 2004
Number of shared co-authors 3
Diya Surie
Centers for Disease Control and Prevention
Career Start Year 2004
Number of shared co-authors 21
Shawn T Brown
Frederick National Laboratory for Cancer Research
Career Start Year 2003
Number of shared co-authors 3
Kayvon Modjarrad
Center for Infectious Diseases Research, Walter Reed Army Institute of Research
Career Start Year 2002
Number of shared co-authors 4
Jennifer R Verani
U.S. Centers for Disease Control and Prevention
Career Start Year 2002
Number of shared co-authors 26
John S Brownstein
Boston Children's Hospital
Career Start Year 2002
Number of shared co-authors 6
Jennifer C Nelson
Kaiser Permanente Washington Health Research Institute
Career Start Year 1998
Number of shared co-authors 2
Brendan Flannery
Centers for Disease Control and Prevention
Career Start Year 1998
Number of shared co-authors 24
John J Grefenstette
University of Pittsburgh
Career Start Year 1998
Number of shared co-authors 2
Meredith L McMorrow
Centers for Disease Control and Prevention
Career Start Year 1995
Number of shared co-authors 24
Daniel G Bausch
London School of Hygiene & Tropical Medicine
Career Start Year 1995
Number of shared co-authors 8
William J Moss
Oak Crest Institute of Science
Career Start Year 1992
Number of shared co-authors 3
Richard K Zimmerman
University of Pittsburgh
Career Start Year 1989
Number of shared co-authors 26
Edward A Belongia
Marshfield Clinic Research Institute
Career Start Year 1987
Number of shared co-authors 12
Gregory A Poland
Mayo Clinic Vaccine Research Group
Career Start Year 1985
Number of shared co-authors 1
Kathryn M Edwards
Vanderbilt University Medical Center
Career Start Year 1980
Number of shared co-authors 7
Arthur Reingold
University of California berkeley
Career Start Year 1971
Number of shared co-authors 5

Collaborators

Natalie E Dean
College of Public Health and Health Professions, University of Florida
Co-authored papers 28
Alessandro Vespignani
Co-authored papers 25
Marco Ajelli
Co-authored papers 12
Maria Litvinova
Co-authored papers 9
Kaiyuan Sun
Co-authored papers 8
Cécile Viboud
Co-authored papers 7
Leora R Feldstein
US Centers for Disease Control and Prevention
Co-authored papers 7
Ali Rowhani-Rahbar
University of Washington
Co-authored papers 6
Pablo Manrique-Saide
Universidad Autonoma de Yucatan
Co-authored papers 5
Hongjie Yu
Co-authored papers 4
Derek A T Cummings
University of Florida
Co-authored papers 4
Gail Potter-Bynoe
National Institute of Allergy and Infectious Diseases
Co-authored papers 4
Alex Pentland
Massachusetts Institute of Technology
Co-authored papers 3
Samuel V Scarpino
Department of Health Sciences Northeastern University
Co-authored papers 3
Manjusha Gaglani
Baylor Scott & White Health and Baylor College of Medicine
Co-authored papers 3
Donald S Burke
Graduate School of Public Health, University of Pittsburghgrid.21925.3d
Co-authored papers 3
Helen K B Talbot
Vanderbilt University Medical Center
Co-authored papers 2
Adrienne Baughman
Vanderbilt University Medical Center
Co-authored papers 2
Carlos G Grijalva
Vanderbilt University Medical Center
Co-authored papers 2
Michael S Aboodi
Montefiore Medical Center, Albert Einstein College of Medicine
Co-authored papers 2
Jay S Steingrub
University of Massachusetts Medical School - Baystate
Co-authored papers 2
Adrienne G Randolph
Boston Children's Hospital, Harvard Medical School
Co-authored papers 2
Akram Khan
Oregon Health and Science University
Co-authored papers 2
Christopher J Lindsell
Duke University
Co-authored papers 2
Adit A Ginde
University of Colorado School of Medicine
Co-authored papers 2
Eduardo Massad
University of Sao Paulo and LIM01-HCFMUSP
Co-authored papers 2
Todd W Rice
Vanderbilt University Medical Center
Co-authored papers 2
Jill M Ferdinands
Centers for Disease Control and Prevention
Co-authored papers 2
Valerie Obenchain
Fred Hutchinson Cancer Research Center
Co-authored papers 2
Matthew E Prekker
Hennepin County Medical Center
Co-authored papers 2
Release 1.2